- Reimagining Reproductive and Developmental Toxicology: Stem Cell–Derived Organoid-Based New Approach Methodologies Across Windows of Susceptibility
-
Hemisfair Ballroom C3‚ Convention Center
Chair: Xian Wu, East Carolina University
Co-Chair: Erik Tokar, NIEHS
Primary Endorser: Stem Cells Specialty Section
Endorser(s): Reproductive and Developmental Toxicology Specialty SectionHow do environmental chemicals ranging from industrial pollutants and engineered nanomaterials to e-cigarette aerosols and complex mixtures affect human reproduction, prenatal development, and lifelong health? Despite decades of research, conventional animal models often fail to predict human outcomes, and standard cell-based systems lack the biological complexity needed to capture how real tissues respond during the most vulnerable stages of life. Closing this gap is one of the most urgent challenges in modern toxicology and the key to better protecting fertility, pregnancy, children’s health, and organ development across the lifespan. This session introduces a bold, forward-looking framework that brings together cutting-edge human stem cell–derived organoid technologies, organ-on- chip engineering, and functional brain models to transform how we evaluate reproductive, developmental, and organ- specific toxicity. Rather than relying on animal testing alone, these next-generation platforms recreate human-relevant biology in the laboratory — from cardiac and brain tissue to ovarian and uterine systems to lung epithelium — enabling researchers, regulators, and industry scientists to ask mechanistic questions that were previously out of reach. The session will open with a brief introduction that explores critical windows of susceptibility — the stages from egg and sperm formation through early embryonic development, organ formation, and fetal programming — when environmental exposures can disrupt reproductive function and developmental trajectories. Consequences range from impaired fertility and adverse pregnancy outcomes to lasting effects on offspring cardiovascular, neural, and respiratory health. Attendees will then learn how human stem cell–derived cardiac and cerebral organoid systems are being used to uncover the effects of environmental toxicants on key developmental stages, including the use of extracellular vesicles and cell-free DNA as early biomarkers of toxicity. The session will also highlight a novel female reproductive system-on-chip that integrates engineered ovarian and uterine tissues, recreating the hormonal and tissue-level interactions essential for understanding how chemicals disrupt reproductive cycles, endometrial preparation, and fertility. From there, attendees will discover how the emerging field of Organoid Intelligence uses high-density electrode recordings in brain organoids to measure synaptic plasticity, network connectivity, and learning-relevant endpoints — providing powerful new readouts for neurodevelopmental toxicity. The session will further demonstrate how air-liquid interface and lung organoid models are advancing the assessment of inhaled pollutants and aerosols on respiratory tissue development, barrier integrity, and immune responses — connecting inhalation toxicology with developmental health. Cross-cutting themes will include epigenetic changes, metabolic reprogramming, neuroinflammation, and hormonal signaling disruption. The session will conclude with a moderated panel discussion exploring how these human-predictive platforms can be integrated into regulatory decision-making through Adverse Outcome Pathway frameworks and artificial intelligence – driven analysis, aligned with recent FDA and NIH initiatives promoting animal-free testing strategies. This session offers valuable insights for professionals across academic research, pharmaceutical development, and public health, providing a deeper understanding of how organoid-based New Approach Methodologies are reshaping toxicological evaluation — moving the field toward human-predictive paradigms that better protect women’s reproductive health, support healthy pregnancies, safeguard children’s development, and advance our understanding of how early-life exposures shape lifelong organ health.
IAT ITS Designation: Innovations in Toxicological Sciences (ITS)
Session and Activity Type
Enter Note
Go to previous page in this tab
Event
